| Stage | XOM | % of rev | DK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $113B | 100.00% | $4.4B | 100.00% | XOM ×25.77 |
| Gross profit | $36.2B | 32.01% | $1.6B | 35.96% | DK +4.0pp |
| Operating income | $21.4B | 18.93% | $1.5B | 34.58% | DK +15.7pp |
| Pre-tax income | $21.2B | 18.77% | $1.5B | 33.43% | DK +14.7pp |
| Net income | $16.0B | 14.16% | $1.2B | 26.24% | DK +12.1pp |
| Stage | XOM | DK | Gap · A − B |
|---|---|---|---|
| Revenue | $113B100.00% | $4.4B100.00% | XOM ×25.77 |
| Gross profit | 32.01%$36.2B | 35.96%$1.6B | DK +4.0pp |
| Operating income | 18.93%$21.4B | 34.58%$1.5B | DK +15.7pp |
| Pre-tax income | 18.77%$21.2B | 33.43%$1.5B | DK +14.7pp |
| Net income |
| 14.16%$16.0B |
| 26.24%$1.2B |
| DK +12.1pp |